Using dexamethasone wisely in invasively ventilated preterm infants
- PMID: 34994096
- DOI: 10.1002/ppul.25819
Using dexamethasone wisely in invasively ventilated preterm infants
Keywords: bronchopulmonary dysplasia (BPD); mechanical ventilation; neonatal pulmonary medicine; oxygenation and therapy.
References
REFERENCES
-
- Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200(6):751-759.
-
- Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Early (<8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017;10:CD001146.
-
- Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL. Late (≥7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2021;11:CD001145.
-
- Rysavy MA, Li L, Tyson JE, et al. Should vitamin A injections to prevent bronchopulmonary dysplasia or death be reserved for high-risk infants? Reanalysis of the National Institute of Child Health and Human Development neonatal research network randomized trial. J Pediatr. 2021;236:78-85.e5.
-
- Kidman AM, Manley BJ, Boland RA, Davis PG, Bhatia R. Predictors and outcomes of extubation failure in extremely preterm infants. J Paediatr Child Health. 2021;57(6):913-919.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical